2010

1. Yamaguchi K, Sakai M, Shimokawa T, Yamada Y, Nakamura Y, Furukawa Y, C20orf20 (MRG-binding protein) as a potential therapeutic target for colorectal cancer. Br. J. Cancer 102:325-31, 2010
2. Inoue M., Senju S., Hirata S., Ikuta Y., Hayashida Y., Irie A., Harao M., Imai K., Tomita Y., Tsunoda T., Furukawa Y., Ito T., Nakamura Y., Baba H., Nishimura Y. Identification of SPARC as a candidate target antigen for immunotherapy of various cancers. International Journal of Cancer. 127: 1393-1403, 2010.
3. Stefanou N, Papanikolaou V, Furukawa Y, Nakamura Y, Tsezou A. Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase. BMC Cancer. 10(1):442, 2010.
4. Nozawa H, Yamada Y, Muto Y, Endo J, Asakage M, Oka T, Furukawa Y, Arai M. Double primary adenocarcinomas of the jejunum and descending colon with lung metastases presenting rare immunohistochemical phenotypes: a case report.Eur J Gastroenterol Hepatol. 22:228-33, 2010.